Overview

A Study of Sensitizing Potential of Diacerein 1% Ointment in Healthy Subjects

Status:
Completed
Trial end date:
2018-03-03
Target enrollment:
Participant gender:
Summary
Single center, randomized, controlled, evaluator blinded, within-subject study to evaluate the sensitization potential of diacerein 1% ointment under occlusive conditions on normal skin of healthy volunteer subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Castle Creek Pharmaceuticals, LLC
Treatments:
Diacetylrhein